Key result
Transcutaneous carbon dioxide (PTCCO2) monitoring estimated arterial CO2 more accurately than end-tidal CO2 (PETCO2) during retroperitoneoscopic urologic surgery, with a smaller absolute difference.
Why the study?
To investigate the accuracy of transcutaneous CO2 pressure (PTCCO2) monitoring and its correlation with arterial CO2 pressure (PaCO2) to determine PaCO2 in patients undergoing retroperitoneoscopic urologic surgery.
Does transcutaneous CO2 pressure (PTCCO2) monitoring improve the accuracy of estimating arterial CO2 pressure (PaCO2) compared to end-tidal CO2 (PETCO2) in patients undergoing retroperitoneoscopic urologic surgery?
Observational (n=50)
No
Does transcutaneous CO2 pressure (PTCCO2) monitoring improve the accuracy of estimating arterial CO2 pressure (PaCO2) compared to end-tidal CO2 (PETCO2) in patients undergoing retroperitoneoscopic urologic surgery?
Transcutaneous CO2 monitoring provides a significantly more accurate and reliable noninvasive estimation of arterial CO2 pressure than end-tidal CO2 monitoring in patients undergoing retroperitoneoscopic urologic surgery.
Answers are grounded in this paper and cite their sources.
PTCCO2 may estimate PaCO2 more accurately than PETCO2 in retroperitoneoscopic surgery; leaves open whether it can safely replace arterial sampling.
Purpose: The aim of the current study was to investigate the accuracy of transcutaneous CO2 pressure (PTCCO2) monitoring and the correlation between it and arterial CO2 pressure (PaCO2), so as to determine PaCO2 in patients undergoing retroperitoneoscopic urologic surgery. Methods: 50 patients undergoing retroperitoneoscopic urologic surgery were enrolled in this study. PaCO2, end-tidal carbon dioxide partial pressure (PETCO2), and PTCCO2 values were measured at 4 time points: before pneumoperitoneum, 30 mins, 60 mins and 90 mins after pneumoperitoneum, respectively. The differences of PaCO2 – PETCO2 and PaCO2 - PTCCO2 were calculated. Paired t test, Bland–Altman method, correlation and regression analysis, as well as Fisher’s exact test were employed for the data analysis. Results: Totally 157 samples were obtained. The mean (SD) of PaCO2, PETCO2 and PTCCO2 were 55.5 (7.2) mmHg, 42.3 (5.2) mmHg and 51.9 (84) mmHg, respectively. The absolute difference of PaCO2-PETCO2 was 13.20 ± 4.43 mmHg and 4.35 ± 2.56 mmHg for PaCO2-PTCCO2 (P < 0.0001). And the correlation coefficient (r) between PaCO2 and PETCO2 was 0.79 (r2 = 0.62, P < 0.0001) , whereas that value between PaCO2 and PTCCO2 was 0.91 (r2 = 0.83, P < 0.0001). Meanwhile, the linear regression between PaCO2 and PETCO2 was PETCO2 = 0.60×PaCO2+9.10 (P < 0.0001), whilst the counterpart between PaCO2 and PTCCO2 was PTCCO2 = 1.07×PaCO2-7.30 (P < 0.0001). The 95% limits of agreement (LOA) of PaCO2 versus PETCO2 was 4.53 to 21.88 mmHg and -3.18 to 10.48 mmHg for PaCO2 versus PTCCO2. Conclusion: PTCCO2 monitoring provided greater accuracy to estimate PaCO2 in patients undergoing retroperitoneoscopic urologic surgery as compared to PETCO2 .
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted an observational in Patients undergoing retroperitoneoscopic urologic surgery (n=50). Transcutaneous carbon dioxide pressure (PTCCO2) monitoring vs. End-tidal carbon dioxide partial pressure (PETCO2) monitoring was evaluated on Absolute difference from arterial carbon dioxide pressure (PaCO2) (p=<0.0001). Transcutaneous carbon dioxide (PTCCO2) monitoring estimated arterial CO2 more accurately than end-tidal CO2 (PETCO2) during retroperitoneoscopic urologic surgery, with a smaller absolute difference.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: